MedPath

Case-control study of the effect of HMG-CoA reductases on subarachnoid hemorrhage

Not Applicable
Conditions
subarachnoid hemorrhage due to ruptured cerebral aneurysm and unruptured cerebral aneurysm
Registration Number
JPRN-UMIN000005963
Lead Sponsor
Department of Neurosurgery, Shiga University of Medical Science
Brief Summary

The risk of subarachnoid hemorrhage may be reduced with the medication of specific drugs.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Cerebral aneurysms due to trauma, dissection, infection, autoimmune diseases, hereditary diseases are excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath